Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

13.0%

3 terminated/withdrawn out of 23 trials

Success Rate

87.0%

+0.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

5%

1 of 20 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
23(100.0%)
23Total
N/A(23)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT02414438Not ApplicableCompleted

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

Role: lead

NCT05192590Not ApplicableCompleted

Establishing Clinical Utility Evidence for Chronic Disease Management Testing

Role: lead

NCT07099001Not ApplicableCompleted

Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

Role: lead

NCT05910684Not ApplicableCompleted

Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study

Role: lead

NCT04693793Not ApplicableCompleted

Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath

Role: lead

NCT05702385Not ApplicableWithdrawn

Clinical Utility Study for Exo-PDAC

Role: lead

NCT05200325Not ApplicableCompleted

Clinical Utility Evidence for TissueCypher®

Role: lead

NCT05910697Not ApplicableTerminated

Clinical Utility of MyProstateScore 2.0 P2

Role: lead

NCT05603299Not ApplicableWithdrawn

Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test

Role: lead

NCT05525806Not ApplicableCompleted

Clinical Utility Study for MyProstateScore+

Role: lead

NCT05658653Not ApplicableCompleted

Clinical Utility of CDMT Among VillageMD Providers

Role: lead

NCT05237271Not ApplicableCompleted

Clinical Utility Trial for the SomaLogic CVD-T2D Test

Role: lead

NCT03765164Not ApplicableCompleted

Glucose Control Using 1,5-AG Testing

Role: lead

NCT04266860Not ApplicableCompleted

Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients

Role: lead

NCT04266821Not ApplicableCompleted

Establishing Clinical Utility of a New Diagnostic Test for Patients Suffering From Pain: A CPV® Randomized Controlled Trial

Role: lead

NCT04550416Not ApplicableCompleted

Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study

Role: lead

NCT03765203Not ApplicableCompleted

Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients

Role: lead

NCT04266834Not ApplicableCompleted

Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization

Role: lead

NCT03800901Not ApplicableCompleted

Quality IQ Patient Simulation Physician Practice Measurement and Engagement

Role: lead

NCT04204018Not ApplicableCompleted

Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia

Role: lead